Baskin, Alison S.
Wang, Ton
Mott, Nicole M.
Hawley, Sarah T.
Jagsi, Reshma
Dossett, Lesly A.
Funding for this research was provided by:
Agency for Healthcare Research and Quality (K08 HS026030-02)
National Cancer Institute (T32 CA009672)
Article History
Received: 17 June 2020
Accepted: 15 July 2020
First Online: 30 July 2020
Disclosures
: Dr. Dossett is supported by grant K08 HS026030-02 from the Agency for Healthcare Research and Quality (AHRQ). Dr. Wang is supported by grant T32 CA009672 from the National Cancer Institute. Dr. Jagsi has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies. She has received personal fees from Amgen and Vizient and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium. Dr. Jagsi has a contract to conduct an investigator-initiated study with Genentech, has served as an expert witness for Sherinian and Hasso and Dressman Benzinger LaVelle and is an uncompensated founding member of TIME’S UP Healthcare and a member of the Board of Directors of ASCO. The remaining authors have no conflicts of interest.